A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
- Status
- RECRUITING
- Phase
- PHASE2
PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tirelizumab in Combination With Carboplatin and Polymeric Micellar Paclitaxel for Neoadjuvant Therapy in cN+ HNSCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE1
FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1
FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Heavy Strength Training in Head and Neck Cancer Survivors
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Lithium-containing Mouthwash Prevention and Treatment of Oral Mucositis and Dysgeusia in Patients Undergoing Radiotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE3
PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1